000			05211nam a22003975i 4500
988			_aSpringer_Medicine_2016
999			_c86937 _d86937 _x1
001			86937
003			ES-MaUEC
005			20230207040621.0
006			a||||fo|||| 00| 0
007			cr nn 008aamaa
008			160616t2016 si |a s |||| 0|eng d
020			_a9789812877062
040			_aES-MaUEC _bspa _dES-MaUEC
050		4	_aRC840.H38 _b2016 EB
245	0	0	_aHelicobacter pylori _cedited by Nayoung Kim
264		1	_aSingapore _bSpringer _c[fecha de publicación no identificada]
264		4	_ccopyright 2016
300			_a1 recurso en línea (X, 556 páginas) _b114 ilustraciones, 103 ilustraciones color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aPart 1. Epidemiology-Prevalence and Transmission routes of H. pylori -- Part 2. Pathophysiology -- 1) Colonization of H. pylori in the stomach -- 2) Brief description of Pathophysiology -- 3) Immune mechanism -- 4) Change of acid secretion, ghrelin and leptin by H. pylori -- 5) H. pylori virulence factors -- A: toxin (CagA, VacA, DupA, OipA, IceA) -- B: genetic polymorphism of toxin and disease -- 6) Host factors: genetic polymorphism, etc -- Part 3. Diagnosis -- 1) Serology -- 2) Histology -- 3) Culture -- 4) UBT -- 5) Stool antigen -- 6) Specific conditions -- A: Children -- B: Bleeding -- Part 4. Symptom -- 1)Symptom of acute and chronic H. pylori infection -- Part 5. Disease -- 1) Atrophic gastritis and Intestinal metaplasia -- 2) Functional dyspepsia -- 3) Peptic ulcer -- 4) MALToma -- 5) Gastric cancer -- A: Synopsis and Epidemiology of gastric cancer -- B1: Pathogenesis: i.Genetic alternation (mutations in tumor-related genes) induced by Activation-induced cytidine deaminase (AID) -- B2: Pathogenesis: ii. Epigenetic mechanisms: aberrant DNA methylation, microRNA -- B3: Pathogenesis:iii. Macrophage inhibitory factor (MIF) -- B4: Pathogenesis: iv. Epidermal mesenchyme transition (EMT) -- B5: Pathogenesis: v. ABO blood type -- B6: Pathogenesis: vi. First relatives of gastric cancer -- C: H. pylori-negative gastric cancer -- 6) Gastroesophageal reflux disease (GERD) -- 7) NSAID-induced gastropathy and H. pylori infection -- 8) Extraintestinal manifestations of H. pylori infection -- A: Iron deficiency anemia -- B: Idiopathic thrombocytopenic purpura -- C: Heart disease -- D: Atopy and allergy -- Part 6. Antibiotic resistance -- 1) Synopsis of antibiotic resistance -- 2) Clarithromycin -- 3) Amoxicillin -- 4) Quinolone -- 5) Metronidazole -- Part 7. Treatment -- 1) Synopsis of antibiotic treatment -- 2) Triple therapy -- 3) Quadruple therapy -- 4) Sequential therapy -- 5) Concomitant therapy -- 6) Tailored therapy based on antibiotic resistance -- 7) Levofloxacin or rifabutin based triple therapy -- 8) Probiotics -- 9) Treatment guidelines -- 10) Screening method of early gastric cancer -- 11) Recrudescence and reinfection -- Part 8. Consequences of H. pylori eradication -- 1) Peptic ulcer disease -- 2) atrophic gastritis and Intestinal metaplasia -- 3) Gastric cancer -- Part 9. The effect of H. pylori on the other microbiota of stomach -- The effect of H. pylori on the other microbiota of stomach -- Part 10. Animal model- H. pylori, H. felis.
520			_aThis book presents the current state of knowledge regarding the ability of Helicobacter pylori to colonize the gastrointestinal tract, the global epidemiology of H. pylori infection, transmission routes, the pathophysiology of H. pylori-related gastroduodenal and other diseases, diagnosis and treatment methods, guidelines for eradication, antibiotic resistance, the reinfection rate after H. pylori eradication, and animal models of H. pylori or related Helicobacter infection. The aim is to equip readers around the world with the understanding required in order to implement effective methods of H. pylori eradication and to enhance clinical outcomes for patients. The text is clearly written and is complemented by many helpful illustrations. This book will be a great asset in clinical practice for all practitioners who are involved in caring for patients with H. pylori-related diseases or have an interest in the subject. It will also be a useful source of information for medical students and for intelligent laypeople seeking information on H. pylori.
650		7	_aInfecciones por Helicobacter pylori _0BNE19950750541 _2embne _9150368
650		7	_aGastroenterología _0BNE19900996790 _2embne _0comprobar BNE19900996790 _9141308
650		7	_9138907 _aBacteriología _0BNE19900965897 _2embne _0comprobar BNE19900965897
700	1		_9101047 _aKim, Nayoung _eeditor literario _0no2009165936
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-981-287-706-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9789812877062
907			_a.b12962156 _b10-10-17 _c21-11-16
942			_2lcc _cLE
945			_aRC840 .H38 H455 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11602302 _z06-04-17
998			_dz _eb _feng _gsi _h0 _b02/2018 _zSI